YTHDF2 and metastatic malignant neoplasm in the lymph nodes: YTHDF2 was significantly associated with certain clinicopathological characteristics, such as lymph node metastasis (Figure 1F), vascular invasion (Figure 1G) and tumour node metastasis (TNM) stage (Figure 1H).